DexCom DXCM Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 237.3%-10.4pp | 247.7%-7.7pp | 255.4%-7.8pp | 263.2%-11.3pp | |
| Operating margin | 68%+2.8pp | 65.2%+6.7pp | 58.5%+16.5pp | 42%-16.0pp | |
| Net margin | 60.1%-5.2pp | 65.3%+18.4pp | 46.9%+7.2pp | 39.7%-54.1pp | |
| EBITDA margin | 89.7%+3.4pp | 86.4%+7.4pp | 79%+16.5pp | 62.5%-11.1pp | |
| Free cash flow margin | 73.8%+12.3pp | 61.4%+4.3pp | 57.2%+25.6pp | 31.6%+7.1pp | |
| Returns | |||||
| Return on equity | 111.7%-6.0pp | 117.6%+43.8pp | 73.8%+21.0pp | 52.9%-72.6pp | |
| Return on assets | 39.6%-0.4pp | 40%+12.7pp | 27.3%+5.1pp | 22.2%-29.9pp | |
| Return on invested capital | 146.6%+10.4pp | 136.2%+49.4pp | 86.8%+5.0pp | 81.8%-50.9pp | |
| Efficiency | |||||
| Asset turnover | 2.6×+0.2× | 2.5×+0.1× | 2.3×+0.1× | 2.2×0.0× | |
| Inventory turnover | 12.4×+0.8× | 11.6×-0.6× | 12.2×+0.7× | 11.4×+0.5× | |
| Liquidity | |||||
| Current ratio | 6.5×-3.2× | 9.6×-0.4× | 10.1×-5.7× | 15.8×-5.8× | |
| Quick ratio | 5.6×-2.8× | 8.4×-0.6× | 9×-5.3× | 14.3×-5.2× | |
| Cash ratio | 1.6×0.0× | 1.6×0.0× | 1.7×-1.4× | 3×-3.5× | |
| Leverage | |||||
| Debt-to-equity | 0.2×-0.1× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Net debt / EBITDA | -4.3×-1.5× | -2.8×+0.9× | -3.7×+1.3× | -5.1×+3.8× | |
| Per Share | |||||
| Book value per share | $25.33+19.8% | $21.15+3.8% | $20.38+3.3% | $19.73-39.5% | |
| Valuation | |||||
| Market capitalization | $113.39B-27.2% | $155.8B-12.6% | $178.26B+15.6% | $154.19B-14.9% | |
| Enterprise value | $109.12B-28.9% | $153.39B-12.8% | $175.89B+15.7% | $152.09B-14.4% | |
| Price / earnings | 177.7×-65.7× | 243.4×-233× | 476.3×-91.4× | 567.7×+123× | |
| Price / sales | 25.8×-14.0× | 39.9×-14.3× | 54.1×-2.4× | 56.6×-23.8× | |
| Price / book | 44.3×-26.1× | 70.3×-12.3× | 82.7×+9.2× | 73.4×-15.9× | |
| EV / EBITDA | 112.1×-68.0× | 180.2×-92.4× | 272.5×-86.8× | 359.3×-75.4× | |
| EV / sales | 24.9×-14.4× | 39.2×-14.2× | 53.4×-2.4× | 55.8×-22.9× | |
| Free cash flow yield | 12%+5.4pp | 6.6%+2.3pp | 4.3%+1.9pp | 2.5%+1.2pp | |
| Earnings yield | 9.6%+2.5pp | 7.1%+3.6pp | 3.6%+0.6pp | 2.9%-1.9pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are DexCom's profit margins?
- DexCom (DXCM) runs a 61.5% gross margin and a 21.4% operating margin, with a 19.3% net margin.
- Where do DexCom's ratios come from?
- Every ratio is computed from DexCom's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
